Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA-DQB1 antisense RNA 1 (HLA-DQB1-AS1) is a long non-coding RNA gene located adjacent to the protein-coding HLA-DQB1 gene in the human major histocompatibility complex (MHC) class II region. HLA-DQB1-AS1 does not code for a protein but exerts regulatory functions by binding to specific RNA-binding proteins, notably ZRANB2, to enhance cell proliferation and inhibit programmed cell death (apoptosis). Its upregulation is implicated in the progression of several cancers, particularly hepatocellular carcinoma, and has also been studied in the context of autoimmune and immune-mediated diseases. HLA-DQB1-AS1 exemplifies a growing class of disease-associated lncRNAs with potential utility as prognostic biomarkers and, potentially, as novel therapeutic targets[2][4][5][6][7].
Interacts directly with RNA-binding proteins (ZRANB2) to promote cell proliferation and inhibit apoptosis[2][4][5] May act as a regulatory lncRNA in disease-associated gene expression[6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA-DQB1 antisense RNA 1 (HLA-DQB1-AS1).